{"id":3789,"date":"2021-07-06T10:08:17","date_gmt":"2021-07-06T14:08:17","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/"},"modified":"2026-07-15T15:58:07","modified_gmt":"2026-07-15T19:58:07","slug":"webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/","title":{"rendered":"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae"},"content":{"rendered":"\nGenSight Biologics annonce qu\u2019un webcast avec des leaders d\u2019opinion (KOLs) se tiendra le <strong>vendredi 9 juillet 2021 de 14h \u00e0 15h CEST (8h-9h EDT)<\/strong>. Les KOLs <strong>Jos\u00e9-Alain Sahel, MD<\/strong> (<em>University of Pittsburgh School of Medicine<\/em>) et <strong>Robert Sergott, MD<\/strong> (<em>Wills Eye Hospital, Philadelphia<\/em>) discuteront des r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ<sup>\u00ae<\/sup> dans le traitement de la Neuropathie Optique H\u00e9r\u00e9ditaire de Leber (NOHL) <a href=\"https:\/\/www.gensight-biologics.com\/fr\/2021\/06\/30\/gensight-biologics-annonce-les-resultats-de-letude-clinique-de-phase-iii-reflect-confirmant-lefficacite-de-lumevoq-et-demontrant-une-meilleure-efficacite-du-traitement-bilater\/\" target=\"_blank\" rel=\"noopener\">publi\u00e9s<\/a> le 30 juin 2021.\n\nA l\u2019issue du webcast, les Drs Sahel et Sergott seront rejoints par l\u2019\u00e9quipe de direction de GenSight pour r\u00e9pondre aux questions.\n\n&nbsp;\n\n<span style=\"color: #33bdbc\"><strong><u>Vendredi 9 juillet 2021<\/u><\/strong>\u00a0<\/span>\n\n14h-15h CEST\n\nWebcast en direct en anglais : <a href=\"https:\/\/bit.ly\/3hetAk6\">https:\/\/bit.ly\/3hetAk6<\/a>\n\nTraduction simultan\u00e9e en fran\u00e7ais : <a href=\"https:\/\/bit.ly\/3hetMzQ\">https:\/\/bit.ly\/3hetMzQ<\/a>\n\nNum\u00e9ro de la conf\u00e9rence t\u00e9l\u00e9phonique :\n<ul>\n \t<li>Paris : +33 (0) 1 7037 7166<\/li>\n \t<li><em>Indiquer que vous rejoignez la conf\u00e9rence GenSight Biologics, en anglais ou en fran\u00e7ais.<\/em><\/li>\n<\/ul>\nIl est n\u00e9cessaire de s\u2019inscrire \u00e0 l&rsquo;avance pour acc\u00e9der aux deux webcasts.\n\nPour ceux qui ne pourront assister \u00e0 la diffusion en direct, un enregistrement sera accessible en utilisant les m\u00eames liens.\n\nLa pr\u00e9sentation est \u00e0 votre disposition pour t\u00e9l\u00e9chargement.\n","protected":false},"excerpt":{"rendered":"<ul>\n<li>Organis\u00e9 par <strong>GenSight Biologics<\/strong> (EPA : SIGHT)<\/li>\n<li>Jour :<strong> vendredi 9 juillet 2021 <\/strong><\/li>\n<li>Heure : <strong>14h-15h CEST <\/strong>(heure locale de Paris)<\/li>\n<\/ul>\n<p>Pour s&rsquo;enregistrer, utiliser les liens suivants :<\/p>\n<ul>\n<li><strong>Webcast en direct en anglais<\/strong> : <a href=\"https:\/\/bit.ly\/3hetAk6\" target=\"_blank\" rel=\"noopener\">https:\/\/bit.ly\/3hetAk6<\/a><\/li>\n<li><strong>Traduction simultan\u00e9e en fran\u00e7ais<\/strong> : <a href=\"https:\/\/bit.ly\/3hetMzQ\" target=\"_blank\" rel=\"noopener\">https:\/\/bit.ly\/3hetMzQ<\/a><\/li>\n<\/ul>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[55],"tags":[],"featured-area":[],"news-topic":[73,79],"news-type":[74,75,76],"post-year":[],"class_list":["post-3789","post","type-post","status-publish","format-standard","hentry","category-evenements","news-topic-gs010-lumevoq","news-topic-company-and-personnel","news-type-product-candidates","news-type-clinical","news-type-corporate"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Organis\u00e9 par GenSight Biologics (EPA : SIGHT)  Jour : vendredi 9 juillet 2021  Heure : 14h-15h CEST (heure locale de Paris) Pour s&#039;enregistrer, utiliser les liens suivants :  Webcast en direct en anglais : https:\/\/bit.ly\/3hetAk6  Traduction simultan\u00e9e en fran\u00e7ais : https:\/\/bit.ly\/3hetMzQ\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-06T14:08:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-15T19:58:07+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae\",\"datePublished\":\"2021-07-06T14:08:17+00:00\",\"dateModified\":\"2026-07-15T19:58:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/\"},\"wordCount\":214,\"articleSection\":[\"Evenements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/\",\"name\":\"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2021-07-06T14:08:17+00:00\",\"dateModified\":\"2026-07-15T19:58:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2021\\\/07\\\/06\\\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/","og_locale":"fr_FR","og_type":"article","og_title":"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae - GenSight Biologics","og_description":"Organis\u00e9 par GenSight Biologics (EPA : SIGHT)  Jour : vendredi 9 juillet 2021  Heure : 14h-15h CEST (heure locale de Paris) Pour s'enregistrer, utiliser les liens suivants :  Webcast en direct en anglais : https:\/\/bit.ly\/3hetAk6  Traduction simultan\u00e9e en fran\u00e7ais : https:\/\/bit.ly\/3hetMzQ","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/","og_site_name":"GenSight Biologics","article_published_time":"2021-07-06T14:08:17+00:00","article_modified_time":"2026-07-15T19:58:07+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae","datePublished":"2021-07-06T14:08:17+00:00","dateModified":"2026-07-15T19:58:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/"},"wordCount":214,"articleSection":["Evenements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/","name":"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2021-07-06T14:08:17+00:00","dateModified":"2026-07-15T19:58:07+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2021\/07\/06\/webcast-avec-des-leaders-dopinion-sur-les-resultats-de-letude-clinique-de-phase-iii-reflect-de-lumevoq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Webcast avec des leaders d\u2019opinion sur les r\u00e9sultats de l\u2019\u00e9tude clinique de Phase III REFLECT de LUMEVOQ\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=3789"}],"version-history":[{"count":0,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3789\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=3789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=3789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=3789"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=3789"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=3789"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=3789"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=3789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}